Position
Fidelity in Immunovant, Inc.
Back to the book · All holders of IMVT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $221.6M$24.84 → $38.53
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 17M | $431.9M | — | — | — | 0.0% |
| Q1 2026 | 16.9M | $421M | $24.84 | −$9.83M | −$1.09M | 0.0% |
| Q2 2026 | 16.2M | $623.7M | $38.53 | $221.6M | −$18.9M | 0.0% |